Connexin channel modulators and their mechanisms of action

Vytautas Verselis, Miduturu Srinivas

Research output: Contribution to journalArticle

40 Citations (Scopus)

Abstract

Gap junction channels and hemichannels formed by the connexin family of proteins play important roles in many aspects of tissue homeostasis in the brain and in other organs. In addition, connexin channels have been proposed as pharmacological targets in the treatment of a number of human disorders. In this review, we describe the connexin-subtype selectivity and specificity of pharmacological agents that are commonly used to modulate connexin channels. We also highlight recent progress made toward identifying new agents for connexin channels that act in a selective and specific manner. Finally, we discuss developing insights into possible mechanisms by which these agents modulate connexin channel function. This article is part of the Special Issue Section entitled 'Current Pharmacology of Gap Junction Channels and Hemichannels'.

Original languageEnglish (US)
Pages (from-to)517-524
Number of pages8
JournalNeuropharmacology
Volume75
DOIs
StatePublished - 2013

Fingerprint

Connexins
Gap Junctions
Pharmacology
Homeostasis
Brain
Proteins

Keywords

  • Connexin
  • Gap junctions
  • Hemichannels
  • Pharmacology

ASJC Scopus subject areas

  • Pharmacology
  • Cellular and Molecular Neuroscience

Cite this

Connexin channel modulators and their mechanisms of action. / Verselis, Vytautas; Srinivas, Miduturu.

In: Neuropharmacology, Vol. 75, 2013, p. 517-524.

Research output: Contribution to journalArticle

@article{1d0aedea56954e4397685138c049d872,
title = "Connexin channel modulators and their mechanisms of action",
abstract = "Gap junction channels and hemichannels formed by the connexin family of proteins play important roles in many aspects of tissue homeostasis in the brain and in other organs. In addition, connexin channels have been proposed as pharmacological targets in the treatment of a number of human disorders. In this review, we describe the connexin-subtype selectivity and specificity of pharmacological agents that are commonly used to modulate connexin channels. We also highlight recent progress made toward identifying new agents for connexin channels that act in a selective and specific manner. Finally, we discuss developing insights into possible mechanisms by which these agents modulate connexin channel function. This article is part of the Special Issue Section entitled 'Current Pharmacology of Gap Junction Channels and Hemichannels'.",
keywords = "Connexin, Gap junctions, Hemichannels, Pharmacology",
author = "Vytautas Verselis and Miduturu Srinivas",
year = "2013",
doi = "10.1016/j.neuropharm.2013.03.020",
language = "English (US)",
volume = "75",
pages = "517--524",
journal = "Neuropharmacology",
issn = "0028-3908",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Connexin channel modulators and their mechanisms of action

AU - Verselis, Vytautas

AU - Srinivas, Miduturu

PY - 2013

Y1 - 2013

N2 - Gap junction channels and hemichannels formed by the connexin family of proteins play important roles in many aspects of tissue homeostasis in the brain and in other organs. In addition, connexin channels have been proposed as pharmacological targets in the treatment of a number of human disorders. In this review, we describe the connexin-subtype selectivity and specificity of pharmacological agents that are commonly used to modulate connexin channels. We also highlight recent progress made toward identifying new agents for connexin channels that act in a selective and specific manner. Finally, we discuss developing insights into possible mechanisms by which these agents modulate connexin channel function. This article is part of the Special Issue Section entitled 'Current Pharmacology of Gap Junction Channels and Hemichannels'.

AB - Gap junction channels and hemichannels formed by the connexin family of proteins play important roles in many aspects of tissue homeostasis in the brain and in other organs. In addition, connexin channels have been proposed as pharmacological targets in the treatment of a number of human disorders. In this review, we describe the connexin-subtype selectivity and specificity of pharmacological agents that are commonly used to modulate connexin channels. We also highlight recent progress made toward identifying new agents for connexin channels that act in a selective and specific manner. Finally, we discuss developing insights into possible mechanisms by which these agents modulate connexin channel function. This article is part of the Special Issue Section entitled 'Current Pharmacology of Gap Junction Channels and Hemichannels'.

KW - Connexin

KW - Gap junctions

KW - Hemichannels

KW - Pharmacology

UR - http://www.scopus.com/inward/record.url?scp=84890441799&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84890441799&partnerID=8YFLogxK

U2 - 10.1016/j.neuropharm.2013.03.020

DO - 10.1016/j.neuropharm.2013.03.020

M3 - Article

C2 - 23597508

AN - SCOPUS:84890441799

VL - 75

SP - 517

EP - 524

JO - Neuropharmacology

JF - Neuropharmacology

SN - 0028-3908

ER -